Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan E Shaw

Showing results (41-50 of 449) with videos related to

Pageof 45
Sort By:
Journal of the American College of Cardiology|January 20, 2018
Implications of Underlying Mechanisms for the Recognition and Management of Diabetic CardiomyopathyThomas H Marwick, Rebecca Ritchie, Jonathan E Shaw, et al.
Diabetes Care|April 29, 2006
Point: impaired fasting glucose: The case for the new American Diabetes Association criterionJonathan E Shaw, Paul Z Zimmet, K George M M Alberti
The Medical Journal of Australia|August 16, 2005
Mainstreaming the metabolic syndrome: a definitive definitionPaul Z Zimmet, K George M M Alberti, Jonathan E Shaw
Metabolic Syndrome and Related Disorders|March 29, 2008
Metabolic syndrome-do we really need a new definition?Jonathan E Shaw, Paul Z Zimmet, K George, et al.
Diabetologia|October 20, 2020
The association of socioeconomic disadvantage and remoteness with receipt of type 2 diabetes medications in Australia: a nationwide registry studyJedidiah I Morton, Jenni Ilomӓki, Dianna J Magliano, et al.
Journal of Diabetes and Its Complications|December 16, 2014
Response to research letter in relation to paper by Bongaerts et al., a clinical screening score for diabetic polyneuropathy: KORA F4 and AusDiab studies (a single question screening test for the detection of diabetic peripheral neuropathy)Brenda W C Bongaerts, Dan Ziegler, Jonathan E Shaw, et al.
Diabetes Research and Clinical Practice|September 14, 2016
Predictors of efficacy of GLP-1 agonists and DPP-4 inhibitors: A systematic reviewHelene Bihan, Winda L Ng, Dianna J Magliano, et al.
Diabetes, Obesity & Metabolism|July 24, 2025
Impact of eligibility for diabetes remission on response to intensive lifestyle intervention in overweight and obese people with type 2 diabetes: The Look AHEAD trialJoanna Y Gong, Agus Salim, Dianna J Magliano, et al.
Diabetes, Obesity & Metabolism|August 18, 2025
Comparison of subcutaneous, visceral, liver and muscle fat depots in relation to prevalent and incident diabetesDanyang Wang, Jedidiah I Morton, Dianna J Magliano, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 12, 2025
Total and excess bed-days in people with diabetes in AustraliaBerhanu Elfu Feleke, Agus Salim, Dianna J Magliano, et al.
Pageof 45

Showing results (41-50 of 449) with videos related to

Sort By:
Pageof 45
Journal of the American College of Cardiology|January 20, 2018
Implications of Underlying Mechanisms for the Recognition and Management of Diabetic CardiomyopathyThomas H Marwick, Rebecca Ritchie, Jonathan E Shaw, et al.
Diabetes Care|April 29, 2006
Point: impaired fasting glucose: The case for the new American Diabetes Association criterionJonathan E Shaw, Paul Z Zimmet, K George M M Alberti
The Medical Journal of Australia|August 16, 2005
Mainstreaming the metabolic syndrome: a definitive definitionPaul Z Zimmet, K George M M Alberti, Jonathan E Shaw
Metabolic Syndrome and Related Disorders|March 29, 2008
Metabolic syndrome-do we really need a new definition?Jonathan E Shaw, Paul Z Zimmet, K George, et al.
Diabetologia|October 20, 2020
The association of socioeconomic disadvantage and remoteness with receipt of type 2 diabetes medications in Australia: a nationwide registry studyJedidiah I Morton, Jenni Ilomӓki, Dianna J Magliano, et al.
Journal of Diabetes and Its Complications|December 16, 2014
Response to research letter in relation to paper by Bongaerts et al., a clinical screening score for diabetic polyneuropathy: KORA F4 and AusDiab studies (a single question screening test for the detection of diabetic peripheral neuropathy)Brenda W C Bongaerts, Dan Ziegler, Jonathan E Shaw, et al.
Diabetes Research and Clinical Practice|September 14, 2016
Predictors of efficacy of GLP-1 agonists and DPP-4 inhibitors: A systematic reviewHelene Bihan, Winda L Ng, Dianna J Magliano, et al.
Diabetes, Obesity & Metabolism|July 24, 2025
Impact of eligibility for diabetes remission on response to intensive lifestyle intervention in overweight and obese people with type 2 diabetes: The Look AHEAD trialJoanna Y Gong, Agus Salim, Dianna J Magliano, et al.
Diabetes, Obesity & Metabolism|August 18, 2025
Comparison of subcutaneous, visceral, liver and muscle fat depots in relation to prevalent and incident diabetesDanyang Wang, Jedidiah I Morton, Dianna J Magliano, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 12, 2025
Total and excess bed-days in people with diabetes in AustraliaBerhanu Elfu Feleke, Agus Salim, Dianna J Magliano, et al.
Pageof 45